HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Wiese Selected Research

4-oxo-4H-chromene-2-carboxylic acid (2- (2- (4- (2- (6,7- dimethoxy- 3,4- dihydro- 1H- isoquinolin- 2- yl)- ethyl)- phenyl)- 2H- tetrazol- 5- yl)- 4,5- dimethoxyphenyl)amide

5/2015HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Wiese Research Topics

Disease

52Neoplasms (Cancer)
11/2021 - 09/2004
31Breast Neoplasms (Breast Cancer)
11/2021 - 07/2006
5Ovarian Neoplasms (Ovarian Cancer)
01/2014 - 09/2005
3Rheumatoid Arthritis
01/2020 - 05/2011
2Neuroblastoma
03/2016 - 02/2015
2Carcinoma (Carcinomatosis)
01/2014 - 04/2013
1Leukemia
02/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2021
1Colonic Neoplasms (Colon Cancer)
01/2020
1Alzheimer Disease (Alzheimer's Disease)
11/2019
1Mercury Poisoning (Poisoning, Mercury)
05/2017
1Inclusion Body Myositis
01/2017
1Polymyositis
01/2017
1Myositis (Idiopathic Inflammatory Myopathies)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1Dermatomyositis (Dermatopolymyositis)
01/2017
1Parkinson Disease (Parkinson's Disease)
11/2016
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2016
1Prostatic Neoplasms (Prostate Cancer)
03/2016
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2015
1Melanoma (Melanoma, Malignant)
10/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2014
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2013
1Neoplasm Metastasis (Metastasis)
08/2012
1Glioma (Gliomas)
12/2010
1Experimental Melanoma
12/2010

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
11/2021 - 07/2006
18Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2021 - 09/2005
16ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020 - 01/2007
16Adenosine Triphosphate (ATP)IBA
01/2020 - 09/2004
11multidrug resistance-associated protein 1IBA
11/2019 - 08/2009
8Carrier Proteins (Binding Protein)IBA
11/2019 - 09/2009
7Pharmaceutical PreparationsIBA
01/2020 - 10/2009
4Cisplatin (Platino)FDA LinkGeneric
01/2014 - 09/2004
3Biological ProductsIBA
11/2021 - 01/2016
3Antineoplastic Agents (Antineoplastics)IBA
02/2019 - 11/2017
3QuinazolinesIBA
10/2017 - 12/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 09/2004
3Daunorubicin (Cerubidine)FDA LinkGeneric
04/2016 - 07/2006
2Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 04/2013
2calcein AMIBA
04/2016 - 08/2009
2Aurora Kinase AIBA
09/2015 - 02/2013
2Biomarkers (Surrogate Marker)IBA
06/2014 - 02/2013
2Drug CarriersIBA
01/2014 - 04/2013
2tariquidar (XR9576)IBA
09/2009 - 03/2006
2WK-X-34IBA
11/2006 - 07/2006
1arcyriaflavin AIBA
01/2020
1Rheumatoid FactorIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Amyloidogenic ProteinsIBA
11/2019
1Membrane Transport Proteins (Biological Pump)IBA
10/2017
1EstersIBA
10/2017
1Antirheumatic Agents (DMARD)IBA
06/2017
1Protein Tyrosine PhosphatasesIBA
01/2017
1PyrimidinesIBA
01/2017
1AutoantibodiesIBA
01/2017
1Monoamine Oxidase (MAO)IBA
11/2016
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2016
1EnzymesIBA
11/2016
1benzothiazoleIBA
07/2016
1Chalcone (Benzalacetophenone)IBA
07/2016
1Chelating AgentsIBA
07/2016
1ThiosemicarbazonesIBA
07/2016
1pirinixic acidIBA
03/2016
1Carbolines (Beta-Carbolines)IBA
01/2016
1QuinolinesIBA
01/2016
1tozasertibIBA
09/2015
1MLN 8237IBA
09/2015
1Aurora KinasesIBA
09/2015
1Multidrug Resistance-Associated ProteinsIBA
09/2015
14-oxo-4H-chromene-2-carboxylic acid (2- (2- (4- (2- (6,7- dimethoxy- 3,4- dihydro- 1H- isoquinolin- 2- yl)- ethyl)- phenyl)- 2H- tetrazol- 5- yl)- 4,5- dimethoxyphenyl)amideIBA
05/2015
1CopperIBA
03/2015
1IronIBA
03/2015
1Small Interfering RNA (siRNA)IBA
02/2015
1flubendazoleIBA
02/2015
1Mitoxantrone (Novantrone)FDA LinkGeneric
10/2014
1VemurafenibIBA
10/2014
1PLX 4720IBA
10/2014
1Vincristine (Oncovin)FDA LinkGeneric
10/2014
1XanthineIBA
08/2014
1AntigensIBA
06/2014
1darapladibIBA
02/2013
1Glutamine (L-Glutamine)FDA Link
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Phenobarbital (Luminal)FDA Link
08/2012
1TamoxifenFDA LinkGeneric
08/2012
1ChalconesIBA
01/2012
1Leflunomide (Arava)FDA LinkGeneric
05/2011
1teriflunomideIBA
05/2011
1FlavonoidsIBA
03/2011
1saquinavir-NOIBA
12/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2010
1Saquinavir (Invirase)FDA Link
12/2010

Therapy/Procedure

17Drug Therapy (Chemotherapy)
11/2021 - 12/2010
12Therapeutics
01/2020 - 08/2012
1Adjuvant Chemotherapy
02/2021
1Medical Day Care (Partial Hospitalization)
05/2017
1Precision Medicine
01/2013